REDWOOD CITY, Calif., July  02, 2026  (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has received an unsolicited, non-binding

SEER

Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.

Seer CEO proposes all-cash sale with CVRs; independent committee to review

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>REDWOOD CITY, Calif., July  02, 2026  (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has received an unsolicited, non-binding</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Seer disclosed an unsolicited, non-binding proposal from its CEO to buy all outstanding Class A shares for $2.45 in cash plus two contingent value rights. The board will form an independent Special Committee to evaluate the offer and alternatives, engaging Perella Weinberg Partners and Wilson Sonsini. No stockholder action is required at this time, and an 8-K will disclose the full text.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>CEO Omid Farokhzad submits unsolicited buyout offer for SEER.</li><li>Offer: $2.45 per share in cash plus two CVRs.</li><li>Seer&#039;s board forms independent Special Committee to evaluate.</li><li>No stockholder action required currently; Form 8-K to disclose full text.</li><li>Advisors: Perella Weinberg Partners advising; Wilson Sonsini legal counsel.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Seer, Inc. (SEER)</strong>: Subject of unsolicited CEO-led buyout; board reviews via independent committee.</li><li><strong>Perella Weinberg Partners (N/A)</strong>: Financial advisor to Seer for deal evaluation.</li><li><strong>Wilson Sonsini Goodrich &amp; Rosati (N/A)</strong>: Legal counsel supporting governance process.</li><li><strong>Omid Farokhzad (N/A)</strong>: CEO and proposal initiator; potential governance and conflict considerations.</li></ul>
  </section>

  <section data-block="category">
    <h3>M&amp;A</h3>
    <p>Category Type: M&amp;A. This is a corporate development event signaling potential take-private considerations, contingent on committee review and deal terms.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Independent Special Committee to assess the proposal reduces governance risk for a potential deal.</li><li>CVRs create optional value but depend on future proteomic milestones.</li><li>Unsolicited CEO proposal signals strategic value but raises governance questions.</li><li>No immediate action required; market reacts to 8-K details and due diligence.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Date: July 2, 2026; Redwood City press release.</li><li>Offer price: $2.45 per share in cash plus two CVRs.</li><li>Special Committee to evaluate; no action required yet.</li><li>Advisors: Perella Weinberg Partners (financial) and Wilson Sonsini (legal).</li><li>Form 8-K will include full text of the proposal.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>The stock could move toward the proposed price upon committee signaling, with CVRs introducing optional upside depending on milestones and deal progress, in the short term.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p>REDWOOD CITY, Calif., July  02, 2026  (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/SEER">SEER</a>), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has received an unsolicited, non-binding proposal from Omid Farokhzad, M.D., Seer’s Chair and Chief Executive Officer, to acquire all of the outstanding shares of Seer’s Class A common stock for $2.45 per share in cash plus two separate contingent value rights (the "Proposal"). The full text of the letter received from Farokhzad, M.D., outlining the Proposal will be included on a Form 8-K filing made by Seer.</p>  <p>Seer’s Board of Directors will establish a Special Committee consisting solely of independent directors. The Special Committee will evaluate the Proposal and other alternatives available to Seer, and determine the course of action that it believes is in the best interests of Seer and its stockholders. The Special Committee will retain independent financial and legal advisors to assist it with its work.</p>  <p>No stockholder action is required at this time.</p>  <p>Perella Weinberg Partners LP is serving as financial advisor to Seer and Wilson Sonsini Goodrich &amp; Rosati, Professional Corporation is serving as legal counsel.</p>  <p><strong>About Seer, Inc.</strong></p>  <p>Seer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/SEER">SEER</a>) sets the standard in deep, unbiased proteomics, delivering insights with a scale, speed, precision and reproducibility previously unattainable. Seer’s Proteograph<sup>&#xAE;</sup> Product Suite integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables and advanced analytical software to overcome the limitations of traditional proteomic methods. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information, visit www.seer.bio.</p>  <p>For more information, please email us at <a href="https://www.globenewswire.com/Tracker?data=pcf1lY3FCEcOEU4ygZKk6AY4-XlqOAQLQv49CAs6h0t8jnq0iQ_-hGR6IWUJemmyiVZouvcL88Fey4YuTh1jhg==" rel="nofollow" target="_blank">pr@seer.bio</a>.</p>  <p><strong>Forward Looking Statements</strong></p>  <p>This communication contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements are based on Seer’s beliefs and assumptions and on information currently available to it on the date of this press release. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause Seer’s actual results, performance, or achievements to be materially different from those expressed or implied by the forward-looking statements. These statements include but are not limited to statements regarding the actions to be taken by the Board and the Special Committee. These and other risks are described more fully in Seer’s filings with the Securities and Exchange Commission and other documents that Seer subsequently files with the Securities and Exchange Commission from time to time. Except to the extent required by law, Seer undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.</p>  <p><strong>Media Contact:</strong><br></br>Patrick Schmidt<br></br>pr@seer.bio</p>  <p>Joele Frank, Wilkinson Brimmer Katcher<br></br>Eric Brielmann / Joseph Sala<br></br>(212) 355-4449</p>  <p><strong>Investor Contact:</strong><br></br>Marissa Bych<br></br>investor@seer.bio</p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTc1NjQ4NCM3Njg5NTM4IzIxOTc0ODQ="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/ZjU0NjA1ZGMtNTk1MC00YTdiLWJhNmEtZGEwZDRkOWIzZDhkLTEyMDkwMzctMjAyNi0wNy0wMi1lbg==/tiny/Seer-Inc-.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/a5aaadad-13a1-4dbd-8ba2-d57cbbc610fb"><img src="https://ml.globenewswire.com/media/a5aaadad-13a1-4dbd-8ba2-d57cbbc610fb/small/seer-brandmark-rgb-full-jpg.jpg" border="0" width="150" height="48" alt="Primary Logo"></img></a></p>

Seer disclosed an unsolicited, non-binding proposal from its CEO to buy all outstanding Class A shares for $2.45 in cash plus two contingent value rights. The board will form an independent Special Committee to evaluate the offer and alternatives, engaging Perella Weinberg Partners and Wilson Sonsini. No stockholder action is required at this time, and an 8-K will disclose the full text.

Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

M&A

Related News